Anthony Accorsi
About Anthony Accorsi
Anthony Accorsi is the Director and Head of Muscle Biology at Fulcrum Therapeutics, where he has worked since 2021. He has extensive experience in muscle biology, cell biology, and cell physiology, having previously held various scientific roles at Fulcrum Therapeutics and Boston University.
Current Role in Muscle Biology
Anthony Accorsi serves as the Director and Head of Muscle Biology at Fulcrum Therapeutics. He has held this position since 2021, overseeing research and development initiatives in muscle biology. His role involves leading projects that focus on innovative approaches to understanding and treating muscle disorders.
Previous Experience at Fulcrum Therapeutics
Anthony Accorsi has a significant history with Fulcrum Therapeutics, where he worked in various capacities. He began as an Associate Scientist in Biology from 2017 to 2018, then progressed to Scientist I in Cell Biology/Cell Physiology from 2018 to 2019. He later served as a Scientist in New Disease Enablement for five months in 2019, followed by a year as Senior Scientist in Muscle Biology from 2020 to 2021.
Academic Background
Anthony Accorsi completed his undergraduate studies at Siena College, earning a Bachelor of Science in Biology from 2009 to 2013. He furthered his education at Boston University, where he obtained a Doctor of Philosophy (Ph.D.) in Human Physiology from 2013 to 2017. His academic background provides a strong foundation for his research in muscle biology.
Research and Teaching Experience
Prior to his roles at Fulcrum Therapeutics, Anthony Accorsi worked as a Research and Teaching Fellow at Boston University, focusing on Regenerative Muscle Disorders from 2013 to 2017. He also served as an MCAT Biology Instructor at The Princeton Review for seven months in 2016 to 2017. These experiences contributed to his expertise in cell biology and physiology.
Focus on Muscle Biology Innovation
Anthony Accorsi is recognized for his strong focus on radical and transformational ideas within the field of muscle biology. His work at Fulcrum Therapeutics emphasizes innovative research and development, contributing significantly to advancements in understanding muscle disorders and potential treatments.